Call for lead investigators for the DETERMINE trial

DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly defined Indications using a National Evaluation platform trial) is a multi-drug, precision medicine trial for adults, teenagers and children with rare cancers. The DETERMINE trial is calling for motivated clinicians who may be interested and/or have experience with rare tumour types and would like to become a lead investigator for one of the treatment arms within the DETERMINE trial. If you are interested, please download the Expresssion of Interest form and send it to DetermineEnquiries@cancer.org.uk by 19 June 2023.

Find out more about DETERMINE